Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet.
Combining pharmacological treatments and life style interventions is necessary for effective therapy of major diseases associated with obesity, which are clustered in the metabolic syndrome. Acting via multiple mechanisms, combination treatments may reduce dose requirements and, therefore, lower the...
Guardado en:
Autores principales: | Vladimir Kus, Pavel Flachs, Ondrej Kuda, Kristina Bardova, Petra Janovska, Michaela Svobodova, Zuzana Macek Jilkova, Martin Rossmeisl, Rui Wang-Sattler, Zhonghao Yu, Thomas Illig, Jan Kopecky |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec7596b0b0bd4d8792261cf113de7428 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice.
por: Olga Horakova, et al.
Publicado: (2012) -
The Chicken Embryo Model: A Novel and Relevant Model for Immune-Based Studies
por: Paul Garcia, et al.
Publicado: (2021) -
Microbial Unmasking of Plant Glycosides
por: Kristen A. Biernat, et al.
Publicado: (2018) -
Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression
por: Giulia Cantini, et al.
Publicado: (2021) -
Unmasking chloride attack on the passive film of metals
por: B. Zhang, et al.
Publicado: (2018)